Galleri Cancer Screening
The Galleri test is a multicancer early detection blood test used to identify more than 50 cancer types in asymptomatic adults.
NEGATIVE PREDICTIVE VALUE IS 98.5%
This means that if Galleri test has a result of "No Cancer Signal Detected", there is a 98.5% chance that this result is likeley a true negative.
SPECIFICITY VALUE IS 99.5%
This means that in approximately 200 people tested, only 1 person would be expected to receive a false positive result.
DECREASE VISCERAL FAT
IMPROVE METABOLIC HEALTH
INCREASE LEAN MUSCLE MASS
IMPROVE ENERGY LEVELS
ONLY 5 CANCERS HAVE A RECOMMENDED SCREENING TEST
Adding Galleri to your cancer screening can increase your chance of finding a signal associated with cancer early.
The Galleri test can detect a signal shared by over 50 types of cancer with 99.5% specificity and predict the cancer signal origin with high accuracy to help guide next steps.
Galleri does not replace other screening tests that your healthcare provider recommends.
Over a period of 4.1 months, patients lost an average of 18 pounds, with an average 10% of total body weight lost.
Averaged 4.8% body fat percentage loss and average gain of 2.9% muscle mass.
Average 32cm squared of visceral fat reduction
Program Success Stories
“I Mean This, Sincerely, You Saved My Life”
After just four months of the Tirzepatide and the Weight Optimization Program, a 57-year-old male executive and Next Health client lost 10 pounds of fat while maintaining muscle mass. His HA1C levels (measure of blood sugar) improved from 11.0% to 7.0%, His energy levels significantly improved, and his partner noticed he no longer snored. As his initial goal was to control his decades-long battle with type 2 diabetes and address his constant fatigue, he is thrilled with his results.
Reversing Diabetes, Meaningful Weight Loss, (and Significant Life Gain) at Age 56.
A 56-year-old female, experiencing the challenges of pre-diabetes, a busy lifestyle, and menopause, joined Next Health’s Health Optimization Program (HOP) with the primary aim of shedding excess weight and boosting her energy levels. After just 4.5 months of Semaglutide and the Weight Optimization Program, she achieved remarkable results. Her HA1C levels (blood sugar levels) dropped to 5.2%, and she accomplished an impressive 37-pound weight loss.
Beating the Odds and Losing Over 20 Pounds
A 38-year-old male, facing issues of being overweight, experiencing low energy levels, and being burdened with a family history of morbid obesity, embarked on his health journey with a primary focus on weight loss, increased energy, and reducing the risk of disease due to his family history. Following just four months of the Tirzepatide and the Weight Optimization Program, he achieved remarkable progress. His weight dropped by 22 pounds, his visceral fat levels (unhealthy organ fat) decreased from 109 to 75, reflecting significant improvements in his health markers.
Am I a good candidate for galleri?
Age is the biggest risk factor for cancer. People 50 and older are 13x more likely to develop cancer than those under 50 y/o. Galleri is recommended for use in adults with an elevated risk of cancer. Prevention and early detection is crucial.
How does the Galleri test work?
The Galleri test screens your blood sample for cell-free DNA and identifies whether it comes from healthy or cancer cells. Galleri leverages DNA sequencing and pattern-recognition technology to screen for the presence of a cancer signal and predict its most likely origin.
All cells, non-cancer and cancer, release DNA fragments, known as cell-free DNA (cfDNA), into the blood. Certain cfDNA methylation patterns are associated with cancer and can be considered a cancer signal. DNA methylation is a process used by cells to regulate gene expression. In cfDNA from cancer, certain regions of DNA are often hypermethylated or hypomethylated and are associated with specific patterns. These abnormal methylation patterns and the resulting change in gene expression can contribute to cancer initiation and progression.